Posts

Showing posts with the label "AMA

The Top 2 Workouts for Children: A Story of Energy, Fun, and Growth

-
Image
The Top 2 Workouts for Children: A Story of Energy, Fun, and Growth Discover the top two workouts for kids: skipping and bodyweight exercises. This fun story shows how these easy workouts help kids stay healthy, feel confident, and have more energy.  by google ### Chapter 1: The Morning of Change It was a bright Saturday morning when Rohan put on his sneakers, grabbed his water bottle, and stepped onto the porch. His mother raised an eyebrow. “Where are you going so early?” she asked. Rohan grinned. “Coach says I’m starting something new today—[the **top 2 workouts for children.**](//about:blank/1) He says they’ll make me strong like a superhero!” That excitement in his eyes was the first step toward something bigger. When workouts are fun and easy, kids don’t see them as chores—they see them as adventures. | | | --- | | [![](//about:blank/2)](//about:blank/1) | | by google | ### Chapter 2: The First Workout – Skipping into Joy At the park, Coach handed Rohan a skip...
Post a Comment
Read more

"AMA Calls for Broader Access to GLP-1 Obesity Medications"

-
Image
 AMA urges insurers, employers, and lawmakers to broaden access to GLP‑1 anti‑obesity drugs—cutting red tape, boosting coverage, and tackling obesity head‑on. Background: GLP‑1s as Transformative Obesity Treatments GLP‑1 receptor agonists mimic gut hormones, suppress appetite, improve insulin regulation, and have been clinically shown to reduce body weight by 15–20 % in adults with obesity . These medications have shifted from diabetes-focused therapy into powerful tools for chronic weight management, offering both metabolic and cardiovascular benefits. Major Hurdles to Access 1. Prior Authorization Constraints Physicians frequently grapple with frequent prior-authorizations—even for dosage adjustments and renewals. This bureaucratic process imposes administrative delays and can discourage prescribing or dose escalation . 2. Insurance Coverage Gaps Less than 20–25% of large employers provide coverage for GLP‑1s in obesity treatment, and Medicare is currently barred by law from cov...
Post a Comment
Read more